Global Erectile Dysfunction Devices Market Size study & Forecast, by Type (Vacuum Constriction Devices, Penile Implants, Shockwave Therapy, Other Devices Types) by Age Group (Less than 40 Years, 40-60 Years, more than 60 Years) by Cause (Vascular Disorder

Global Erectile Dysfunction Devices Market Size study & Forecast, by Type (Vacuum Constriction Devices, Penile Implants, Shockwave Therapy, Other Devices Types) by Age Group (Less than 40 Years, 40-60 Years, more than 60 Years) by Cause (Vascular Disorder and Diabetes, Neurological Disorder, Other Causes) by End User (Hospitals and ASCs, Clinics) and Regional Analysis, 2023-2030

Global Erectile Dysfunction Devices Market is valued approximately USD 1.6 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 8.8% over the forecast period 2023-2030. Erectile dysfunction devices are specially designed to help men who have difficulty achieving or maintaining an erection. These devices are used as a non-invasive and drug-free alternative to other treatment options. They work by creating a vacuum or applying pressure to the penis, which helps draw blood into the organ and create an erection. Other devices, such as penile implants, are surgically placed in the penis to provide rigidity and support during sexual activity. These devices aim to assist men in achieving satisfactory sexual function and improve their overall sexual health. Its driving factors are prevalence of erectile dysfunction and increasing geriatric population.

According to Single Care, The worldwide prevalence of erectile dysfunction is expected to increase to 322 million men by 2025.According to WHO in 2022, by 2030 there will be 6 out of 1 people will be aged 60 year over. As in 2020 there were 1.4 billion people aged over 60 years. By 2050 the worlds’ population of people aged 60 years and older will be double (2.1 billion) which can increase the number of patient suffering from erectile dysfunction. Moreover, growing aging population, telemedicine and online platforms can create more opportunities in the market. However, the high regulatory and safety concerns, lack of awareness and education stifles market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Erectile Dysfunction Devices Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022. North America dominated the market due to sedentary lifestyle and growing number of people living with diabetes and CVD’s technologically advanced devices are available and the infrastructure of healthcare is well-established. Asia-Pacific and Latin America, have shown significant potential for growth in the ED devices market. Factors such as increasing healthcare expenditure, improving healthcare infrastructure, rising awareness about sexual health, and a larger aging population in these regions contribute to the market's growth potential.

Major market player included in this report are:
Boston Scientific Corporation
Rigico Inc
Coloplast Group
Promedon GmbH
Zephyr Surgical Implants
STORZ MEDICAL AG
VIVUS Inc
Augusta Medical Systems LLC
Reflexonic LLC
Infinium Medical
Recent Developments in the Market:
 In 2023, Rigicon Inc introduced the HL-LEVINE combo prothesis tool, a combination of the HL dilator tool and the traditional Furlow instrument. Which can be used for penile implant surgery.
 In 2022, Advanced Medtech acquired Shenzhen Huikang medical apparatus. This acquisition expanded advanced medtech’s urological market access in China.

Global Erectile Dysfunction Devices Market Report Scope:
 Historical Data – 2020 - 2021
 Base Year for Estimation – 2022
 Forecast period - 2023-2030
 Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
 Segments Covered – Type, Age Group, Cause, End User, Region
 Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa


The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Type:
Vacuum Constriction Devices
Penile Implants
Shockwave Therapy
Other Devices Types

By Age Group:
Less Than 40 Years
40-60 Years
More than 60 years

By Cause:
Vascular Disorder and Diabetes
Neurological Disorder
Other Causes

By End-User:
Hospitals ASCs
Clinics

By Region:

North America
U.S.
Canada

Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC

Latin America
Brazil
Mexico

Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.

Companies Mentioned
Boston Scientific Corporation
Rigico Inc
Coloplast Group
Promedon GmbH
Zephyr Surgical Implants
STORZ MEDICAL AG
VIVUS Inc
Augusta Medical Systems LLC
Reflexonic LLC
Infinium Medical

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.